HK1068884A1 - 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt - Google Patents

5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt

Info

Publication number
HK1068884A1
HK1068884A1 HK05101352A HK05101352A HK1068884A1 HK 1068884 A1 HK1068884 A1 HK 1068884A1 HK 05101352 A HK05101352 A HK 05101352A HK 05101352 A HK05101352 A HK 05101352A HK 1068884 A1 HK1068884 A1 HK 1068884A1
Authority
HK
Hong Kong
Prior art keywords
thiazolidine
pyridyl
ethoxy
amino
methyl
Prior art date
Application number
HK05101352A
Other languages
English (en)
Inventor
Andrew Simon Craig
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127937A external-priority patent/GB0127937D0/en
Priority claimed from GB0127935A external-priority patent/GB0127935D0/en
Priority claimed from GB0127934A external-priority patent/GB0127934D0/en
Priority claimed from GB0127936A external-priority patent/GB0127936D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HK1068884A1 publication Critical patent/HK1068884A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HK05101352A 2001-11-21 2005-02-17 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt HK1068884A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0127937A GB0127937D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127935A GB0127935D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127934A GB0127934D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127936A GB0127936D0 (en) 2001-11-21 2001-11-21 Novel compounds
PCT/GB2002/005232 WO2003045946A1 (en) 2001-11-21 2002-11-21 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient

Publications (1)

Publication Number Publication Date
HK1068884A1 true HK1068884A1 (en) 2005-05-06

Family

ID=27448006

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05101352A HK1068884A1 (en) 2001-11-21 2005-02-17 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt

Country Status (14)

Country Link
EP (1) EP1448559B1 (ko)
JP (1) JP2005513038A (ko)
KR (1) KR20040062963A (ko)
CN (1) CN100390170C (ko)
AT (1) ATE349444T1 (ko)
AU (1) AU2002343050A1 (ko)
CY (1) CY1106397T1 (ko)
DE (1) DE60217168T2 (ko)
DK (1) DK1448559T3 (ko)
ES (1) ES2278977T3 (ko)
HK (1) HK1068884A1 (ko)
PT (1) PT1448559E (ko)
SI (1) SI1448559T1 (ko)
WO (1) WO2003045946A1 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
US20040082620A1 (en) * 2000-12-22 2004-04-29 Craig Andrew Simon 5'-4-'2-(n-methyl-n-(2-pyridyl)amino)ethoxy!benzyl!thiazolidine-2, 4-dione mesylate salt

Also Published As

Publication number Publication date
SI1448559T1 (sl) 2007-06-30
ATE349444T1 (de) 2007-01-15
PT1448559E (pt) 2007-03-30
KR20040062963A (ko) 2004-07-09
JP2005513038A (ja) 2005-05-12
CN100390170C (zh) 2008-05-28
ES2278977T3 (es) 2007-08-16
DK1448559T3 (da) 2007-04-30
EP1448559B1 (en) 2006-12-27
WO2003045946A1 (en) 2003-06-05
CY1106397T1 (el) 2011-10-12
AU2002343050A1 (en) 2003-06-10
CN1612875A (zh) 2005-05-04
DE60217168D1 (de) 2007-02-08
DE60217168T2 (de) 2007-10-04
EP1448559A1 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
AP1814A (en) Tartrate salts of thiazolidinedione derivative.
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
HK1057204A1 (en) A thiazolidinedione derivative and its use as antidiabetic
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
EA200300232A1 (ru) Тартратные соли производного тиазолидиндиона

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20101121